Literature DB >> 8431210

Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells.

P P Sfikakis1, V L Souliotis, P P Panayiotidis.   

Abstract

OBJECTIVE: To further investigate the mechanism of action of gold compounds by studying their effects on interleukin-2 (IL-2) and IL-2 receptor (IL-2R) biosynthesis.
METHODS: We cultured phytohemagglutinin- or anti-CD3 antibody-activated normal peripheral blood mononuclear cells (PBMC), as well as the erythroleukemic K562 cell line, in the presence of gold sodium thiomalate or auranofin. Tritiated thymidine incorporation assays, cytotoxicity assays, immunofluorescence analysis, enzyme-linked immunosorbent assay, Northern blot, and RNA dot-blot hybridization were used.
RESULTS: Gold compounds, at concentrations attainable in vivo, inhibited the proliferation of normal PBMC, with no evidence of direct cytotoxicity. This inhibitory effect was associated with a dose-dependent suppression of both IL-2 and IL-2R messenger RNA accumulation. In contrast, the same concentrations of gold compounds failed to inhibit the spontaneous proliferation of the IL-2-independent K562 cells.
CONCLUSION: Our findings suggest an IL-2/IL-2R-mediated mechanism for suppression of lymphocyte proliferation by gold compounds, which might account for the immunomodulatory effects of gold in patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431210     DOI: 10.1002/art.1780360211

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1.

Authors:  Y Ichibangase; M Yamamoto; M Yasuda; N Houki; M Nobunaga
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.

Authors:  T Matsumoto; K Iwasaki
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

Review 3.  The association of systemic lupus erythematosus and myasthenia gravis.

Authors:  G Vaiopoulos; P P Sfikakis; V Kapsimali; K Boki; P Panayiotidis; A Aessopos; G C Tsokos; P Kaklamanis
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

4.  Gold salts inhibit osteoclastic bone resorption in vitro.

Authors:  T J Hall; H Jeker; H Nyugen; M Schaeublin
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

5.  Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms.

Authors:  Michael Seitz; Jean Valbracht; Jacqueline Quach; Martin Lotz
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.317

6.  Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis.

Authors:  Atsuo Tanimoto; Yuichi Shinozaki; Keisuke Nozawa; Yukari Kimoto; Wataru Amano; Akira Matsuo; Takayuki Yamaguchi; Mutsuyoshi Matsushita
Journal:  BMC Musculoskelet Disord       Date:  2015-11-06       Impact factor: 2.362

7.  NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice.

Authors:  Xinlai Cheng; Stefanie Haeberle; Iart Luca Shytaj; Rodrigo A Gama-Brambila; Jannick Theobald; Shahrouz Ghafoory; Jessica Wölker; Uttara Basu; Claudia Schmidt; Annika Timm; Katerina Taškova; Andrea S Bauer; Jörg Hoheisel; Nikolaos Tsopoulidis; Oliver T Fackler; Andrea Savarino; Miguel A Andrade-Navarro; Ingo Ott; Marina Lusic; Eva N Hadaschik; Stefan Wölfl
Journal:  Commun Biol       Date:  2020-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.